Filing Details
- Accession Number:
- 0001144204-14-006198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-05 17:06:33
- Reporting Period:
- 2014-01-22
- Filing Date:
- 2014-02-05
- Accepted Time:
- 2014-02-05 17:06:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1175151 | Cytosorbents Corp | CTSO | Surgical & Medical Instruments & Apparatus (3841) | 980373793 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1368151 | Vincent Capponi | 7 Deer Park Drive, Suite K Monmouth Junction NJ 08852 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock; Par Value $0.001 Per Share | Disposition | 2014-01-22 | 100,000 | $0.27 | 8,150,586 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2014-01-22 | 100,000 | $0.00 | 100,000 | $0.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,100,000 | 2011-09-07 | 2018-06-25 | No | 4 | M | Direct |
Footnotes
- The shares of common stock sold by Mr. Capponi pursuant to a 10b5-1 trading plan, adopted by the reporting person on June 14, 2011.
- These stock options were granted to Mr. Capponi on June 25, 2008.
- As reported on prior Form 4s these shares consist of (a) 418,086 shares of common stock; (b) 50,000 stock options with an exercise price of $1.65 that expire on 12/31/2016; (c) 1,100,000 stock options with an exercise price of $0.25 that expire on 1/16/2018 (d) 2,100,000 stock options with an exercise price of $0.035 that expire on 6/25/2018; (e) 400,000 stock options with an exercise price of $0.168 that expire on 1/28/2019; (f) 500,000 stock options with an exercise price of $0.173 that expire on 1/4/2020; (g) 2,032,500 stock options with an exercise price of $0.138 that expire on 5/5/2020; and (h) 1,550,000 stock options with an exercise price of $0.115 that expire on 4/4/2023.